System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Pol Camps-Renom is an expert in Neurology at Hospital de Sant Pau (Spain). As of October 2026, ScienceLeadR ranks Pol Camps-Renom in the top 1% of experts worldwide for Cerebrovascular Disorders. Pol Camps-Renom has authored 183 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 4 of them ongoing. SLR score: 758 (community average: 125). How the SLR is computed.

LeadR Profile

Pol Camps-Renom Hospital de Sant Pau Spain
758 ScienceLeadR Reputation 758

Unlock

Register Login
Network Map

Neurology

Subspecialties: Cardiology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1999 - 2026
Source: PubMed

Hospital de Sant Pau

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 183

Citations

Citations: 6 415 1st author: 32 Last author: 11 Unique author: 1

Main journals

Stroke 19
J Med Chem 9
Neurology 9
Eur J Neurol 7
Eur Stroke J 7

Best Journals

JAMA 3
Lancet Neurol 3
N Engl J Med 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
White Matter Hyperintensities on Admission CT are Associated with Worse Outcomes But Not Cerebral Edema or Hemorrhagic Transformation After Large Vessel Occlusion Stroke.
PMID 42509480 — white matter, blood, stroke, biomarkers, reperfusion, thrombectomy, edema		Neurocrit Care20260
Simple against advanced imaging for the selection of stroke therapy in the extended window (VESTA study).
PMID 42308555 — mortality, stroke, therapeutics		Eur Stroke J20260
Visual versus automated collateral scoring on CT angiography for predicting outcome after endovascular therapy for large-vessel occlusion stroke: a prospective multicentre study.
PMID 42274735 — stroke, angiography, radiography, therapeutics, computed tomography angiography		Neuroradiology20260
Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial.
PMID 42258192 — blood, ischemic stroke, stroke, blood pressure, antihypertensive agents, reperfusion, therapeutics, nervous system diseases		JAMA Neurol20260
White Matter Hyperintensities on Admission CT Are Associated with Worse Outcomes but not Cerebral Edema or Hemorrhagic Transformation after Large Vessel Occlusion Stroke.
PMID 42239746 — white matter, blood, stroke, biomarkers, reperfusion, thrombectomy, edema		Res Sq20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 9
N/A 6
Phase 4 2
Phase 2/Phase 3 1

By status:

Completed 8
Unknown 4
Active not recruiting 2
Recruiting 2
Terminated 2

By type:

Interventional 13
Observational 5

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 2
multicentricup10 11

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to test if tenecteplase helps people to recover from an acute stroke when given more than 4 5 hours after the person was last seen well
2025-522542-40-00 — safety, ischemic stroke, stroke, tenecteplase, tissues		Phase 3Recruiting2026
A Phase 3 Placebo controlled Study of Milvexian after an Acute Ischemic Stroke or High Risk Transient Ischemic Attack
2022-501176-26-00 — safety, ischemic stroke, stroke, ischemic attack, transient, factor xia, factor xia inhibitor		Phase 3Active not recruiting2023
CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2)
NCT05797792 — embolectomy, ischemic stroke, stroke, plasminogen, plasminogen activators, tissue plasminogen activator, reperfusion, tissues, thrombectomy		Phase 3Active not recruiting2023
Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke
NCT04892511 — research design, labetalol, phenylephrine, blood, ischemic stroke, stroke, pharmaceutical preparations, blood pressure, infusion pumps, therapeutics, cerebral infarction, infusions, intravenous, thrombectomy, ischemia, hemodynamics		Phase 4Recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS